Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Proprietary compound preparation BNF 0905013
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Valupak Magnesium tablets
090501300BBFLA0
|
Proprietary compound preparation BNF 0905013 | Other magnesium preparations | Nutrition and Blood | 229 |
|
FSC Magnesium & B6 tablets
090501300BBAJA0
|
Proprietary compound preparation BNF 0905013 | Other magnesium preparations | Nutrition and Blood | 2 |
|
Solgar Chelated Magnesium 100mg tablets
090501300BBBHA0
|
Proprietary compound preparation BNF 0905013 | Other magnesium preparations | Nutrition and Blood | 1 |
|
Bio-Magnesium tablets
090501300BBEIA0
|
Proprietary compound preparation BNF 0905013 | Other magnesium preparations | Nutrition and Blood | No data available |
|
Slow-Mag 535mg gastro-resistant tablets
090501300BBFVA0
|
Proprietary compound preparation BNF 0905013 | Other magnesium preparations | Nutrition and Blood | No data available |
|
Slow-Mag 535mg/110mg gastro-resistant tablets
090501300BBFUA0
|
Proprietary compound preparation BNF 0905013 | Other magnesium preparations | Nutrition and Blood | No data available |
|
Ultra Magnesium tablets
090501300BBFWBK
|
Proprietary compound preparation BNF 0905013 | Other magnesium preparations | Nutrition and Blood | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.